Liposomal Bupivacaine Single-Injection Interscalene Block vs. Continuous Interscalene Block for Primary Total Shoulder Arthroplasty
Clinical trial NCT05005260 · COMPLETED
Trial details
- NCT number
- NCT05005260
- Sponsor
- Mayo Clinic
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-14
- Primary completion
- 2023-03-18
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.